Table 6.

Effect of SBIRT on subsequent alcohol or drug diagnosis in Medicaid claims during 1 year following SBIRT screening among those with an SUD diagnosis at baseline (n = 1,249)^*

Variable	Exp (B)	SE	p	[95% CI], Exp (B)
SBIRT	1.299	.168	.043	[1.008, 1.675]
Age group
18-24	Reference
25-34	1.517	.401	.114	[0.904, 2.546]
35-44	1.515	.455	.166	[0.841, 2.728]
45-54	1.687	.431	.040	[1.023, 2.782]
55-64	1.825	.682	.107	[0.879, 3.789]
Female	1.070	.630	.526	[0.868, 1.320]
Race
White (including Hispanic)	Reference
Black	.460	.065	.000	[0.677, 1.082]
Other	.769	.152	.183	[0.523, 1.132]
Mental health diagnosis-baseline	2.146	.709	.021	[1.123, 4.100]
Tobacco use diagnosis-baseline	1.099	.121	.391	[0.886, 1.363]

^*Notes: Result of multi-level mixed effects generalized linear logit model. Additional covariates were clinic, months of Medicaid eligibility at baseline, baseline Medicaid utilization, Supplemental Security Income status, chronic disease diagnoses, and Pregnancy by Sex interaction. SBIRT = Screening, Brief Intervention and Referral to Treatment; CI = confidence interval.